StonvexLoading…
StonvexStonvexStonvexCore line items from CPRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-07-31 | Annual 2024 2024-07-31 | Annual 2023 2023-07-31 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $4.65B | $4.24B | $3.87B | $3.50B |
Operating Income | $1.70B | $1.57B | $1.49B | $1.37B |
Net Income | $1.55B | $1.36B | $1.24B | $1.09B |
EPS (Diluted) | $1.59 | $1.40 | $1.28 | $1.13 |
Total Assets | $10.09B | $8.43B | $6.74B | $5.31B |
Total Liabilities | $883.41M | $879.21M | $750.44M | $683.26M |
Cash & Equivalents | $2.78B | $1.51B | $957.39M | $1.38B |
Free Cash Flow OCF − CapEx | $1.23B | $961.57M | $847.57M | $839.24M |
Shares Outstanding | 967.48M | 962.97M | 957.34M | 952.16M |